Riskpilot← Back to searchSign inGet full accessENGBLOM HMS OG FYSIOTERAPI AS
ASActiveOrg 922025754Kjerkvegen 1C, 7860 Skage I NamdalenPhysiotherapy activities · NACE 8695Est. 20195 employees
Revenue 2024
NOK 1,6M
+3% vs 2023
EBITDA margin
3.9%
+9% vs 2023
Equity ratio
72.8%
Financial strength
Net profit 2024
NOK 41K
+18% vs 2023
| Revenue | NOK 1,6M | +3% |
| EBITDA | NOK 63K | +9% |
| Net profit | NOK 41K | +18% |
| Total assets | NOK 838K | +1% |
| Equity | NOK 610K | -1% |
| Employees | 5 | — |
Legal name
ENGBLOM HMS OG FYSIOTERAPI AS
Org number
922025754
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
8. januar 2019
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Fysioterapitjenester, konsulenttjenester innenfor bedriftshelsetjeneste og alt som naturlig hører sammen med dette, herunder å delta i andre selskap med lignende virksomhet.
Address
Kjerkvegen 1C, 7860 Skage I Namdalen
Phone
+4798814913
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 297 | 1 855 | 1 682 | 1 571 | 1 611 |
| Staff expenses | −670 | −763 | −922 | −967 | −980 |
| EBITDA | 187 | 612 | 242 | 58 | 63 |
| Depreciation & amort. | −1 | −8 | −9 | −14 | −10 |
| EBIT | 185 | 605 | 233 | 43 | 53 |
| Net financials | −1 | −0 | −0 | 1 | 1 |
| Profit before tax | 185 | 605 | 232 | 44 | 54 |
| Tax | 41 | 133 | 51 | 10 | 13 |
| Net profit | 144 | 472 | 181 | 35 | 41 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 427 | 907 | 923 | 831 | 838 |
| Equity | 181 | 553 | 634 | 619 | 610 |
| Long-term debt | 1 | 4 | 6 | 2 | 5 |
| Short-term debt | 244 | 351 | 282 | 210 | 223 |
| Total debt | 246 | 354 | 288 | 212 | 228 |
EBITDA margin
3.9%
This company
15.8%
Market median
-75% vs market
20202024
Equity ratio
72.8%
This company
38.2%
Market median
+91% vs market
20202024
Return on equity
6.7%
This company
18.4%
Market median
-64% vs market
20202024
Net profit margin
2.5%
This company
8.1%
Market median
-69% vs market
20202024
Asset turnover
1.92×
This company
1.12×
Market median
+71% vs market
20202024
Debt / equity
0.37×
This company
0.62×
Market median
+40% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2023 | |
| Board of Directors | 2019 | |
| Chairman | 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ENGBLOM HMS OG FYSIOTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tuva Pernille Engblom | Board of Directors | 0 companies |
| Ivan Kristian Skaret Engblom | Board of Directors | 0 companies |
| Mai-Kristin Skaret Engblom | Board of Directors | 0 companies |
| Kent Daniel Engblom | Chairman | 0 companies |